Opus Genetics (IRD) Cash from Investing Activities Growth (3y) (2013 - 2024)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 116.52% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 38.24% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -22.09% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 30.54% |
| 10 | Opus Genetics | 357.99 Mn | 298.03 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 141.59% |
| Dec 31, 2021 | -27.03% |
| Dec 31, 2020 | 29.58% |
| Dec 31, 2019 | -26.54% |
| Sep 30, 2019 | 52.89% |
| Jun 30, 2019 | 6.52% |
| Mar 31, 2019 | -97.40% |
| Dec 31, 2018 | 35.13% |
| Sep 30, 2018 | -19.25% |
| Jun 30, 2018 | 7.22% |
| Mar 31, 2018 | -10.89% |
| Dec 31, 2017 | -11.10% |
| Sep 30, 2017 | 28.99% |
| Jun 30, 2017 | -413.85% |
| Mar 31, 2017 | 190.99% |
| Dec 31, 2016 | 147.31% |
| Sep 30, 2016 | -407.07% |
| Jun 30, 2016 | 85.62% |
| Mar 31, 2016 | -97.63% |
| Dec 31, 2015 | -69.74% |
| Sep 30, 2015 | 133.50% |
| Jun 30, 2015 | 3.72% |
| Mar 31, 2015 | 200.49% |
| Dec 31, 2014 | -51.61% |
| Sep 30, 2014 | -351.39% |
| Jun 30, 2014 | -52.04% |
| Mar 31, 2014 | 26.20% |
| Dec 31, 2013 | 31.79% |
| Sep 30, 2013 | 26.78% |